16 May, 2017
Almothihel Medical and Chordate Medical launch K.O.S treatment for Non-Allergic Rhinitis in Saudi Arabia.
A launch meeting will be held on ‘Where are we heading in the treatment of Non Allergic Rhinitis. A new innovation’ organized by the distributor Almothihel Medical and Chordate Medical.
May 16, 2017—Almothihel Medical Est. and Chordate Medical AB, announce the launch of the Kinetic Oscillation Stimulation, K.O.S treatment for Non-Allergic Rhinitis, NAR in Saudi Arabia. To support the market entry in Saudi Arabia a meeeting for ENT specialists is being organized. The event is taking place on the 16th of May at the Intercontinental Hotel Corniche Al Hamra Jeddah. Chairman of the meeting is Professor Tarig Jamal, King Abdulaziz University medical school and hospital, Jeddah.
If you want to read our press releases, there are available in the Investor Relations section or by clicking the link below.
For questions about Chordate's share price or other investment-related topics, please see if the answer is here.
For questions about the medical effects of the K.O.S treatment, please see if the answer is here.
To get in touch with Chordate regarding other questions, use the adjecent form. We do our best to respond as quickly as possible.